This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Richter Gedeon Nyrt.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of István Ledneczki
Introduction
István Ledneczki is a notable inventor based in Bölcske, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thiadiazine derivatives. His research focuses on the development of compounds that can modulate the activity of the α7 nicotinic acetylcholine receptor, which is crucial for various biological functions.
Latest Patents
Ledneczki holds a patent for thiadiazine derivatives, which includes pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates, and hydrates. This invention is particularly relevant for its potential applications in pharmaceutical compositions aimed at enhancing receptor activity in mammalian subjects. His patent is a testament to his innovative approach in drug development.
Career Highlights
Throughout his career, István Ledneczki has been associated with Richter Gedeon Nyrt., a prominent pharmaceutical company. His work there has allowed him to explore and develop new therapeutic agents that can have a significant impact on healthcare. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Ledneczki has collaborated with esteemed colleagues such as János Éles and Pál Tapolcsányi. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in pharmaceuticals.
Conclusion
István Ledneczki's contributions to the field of pharmaceuticals through his patent on thiadiazine derivatives highlight his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
